1 FLUTICASONE PROPIONATE | 340 of 4880 | 650 prescriptions Less than 1% of all prescriptions | | 640 patients 18% of all patients | < 11 | |
2 DOXYCYCLINE HYCLATE | 10 of 1980 | 1090 prescriptions Less than 1% of all prescriptions | 980 | 1070 patients 30% of all patients | 960 patients 27% of all patients | A |
3 VENTOLIN HFA (ALBUTEROL SULFATE) | 790 of 5120 | 200 prescriptions Less than 1% of all prescriptions | | 200 patients 6% of all patients | < 11 | |
4 METHYLPREDNISOLONE | 40 of 1200 | 680 prescriptions Less than 1% of all prescriptions | | 660 patients 19% of all patients | < 11 | |
5 CEPHALEXIN | 370 of 4550 | 340 prescriptions Less than 1% of all prescriptions | 340 | 330 patients 9% of all patients | 330 patients 9% of all patients | A |
6 DOXYCYCLINE MONOHYDRATE | 130 of 1100 | 340 prescriptions Less than 1% of all prescriptions | | 340 patients 10% of all patients | < 11 | A |
7 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 270 of 3520 | 280 prescriptions Less than 1% of all prescriptions | | 280 patients 8% of all patients | < 11 | A |
8 TRIAMCINOLONE ACETONIDE | 440 of 2710 | 130 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | |
9 PREDNISONE | 1040 of 7470 | 150 prescriptions Less than 1% of all prescriptions | | 150 patients 4% of all patients | < 11 | |
10 CEFDINIR | 320 of 1410 | 140 prescriptions Less than 1% of all prescriptions | | 140 patients 4% of all patients | < 11 | A |
11 VALACYCLOVIR (VALACYCLOVIR HCL) | 190 of 870 | 120 prescriptions Less than 1% of all prescriptions | | 120 patients 3% of all patients | < 11 | |
12 AZITHROMYCIN | 590 of 5100 | 200 prescriptions Less than 1% of all prescriptions | | 200 patients 6% of all patients | < 11 | A |
13 NITROFURANTOIN MONO-MACRO (NITROFURANTOIN MONOHYD/M-CRYST) | 320 of 2080 | 130 prescriptions Less than 1% of all prescriptions | | 120 patients 3% of all patients | < 11 | A |
14 CIPROFLOXACIN HCL | 400 of 2740 | 110 prescriptions Less than 1% of all prescriptions | | 110 patients 3% of all patients | < 11 | A |